AR087330A1 - Fago modificado geneticamente y uso del mismo - Google Patents

Fago modificado geneticamente y uso del mismo

Info

Publication number
AR087330A1
AR087330A1 ARP120102472A ARP120102472A AR087330A1 AR 087330 A1 AR087330 A1 AR 087330A1 AR P120102472 A ARP120102472 A AR P120102472A AR P120102472 A ARP120102472 A AR P120102472A AR 087330 A1 AR087330 A1 AR 087330A1
Authority
AR
Argentina
Prior art keywords
genetically modified
same
modified payment
inactivated
payment
Prior art date
Application number
ARP120102472A
Other languages
English (en)
Inventor
Cedric Szpirer
Original Assignee
Delphi Genetics Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11173033A external-priority patent/EP2543720A1/en
Priority claimed from US13/178,402 external-priority patent/US9920323B2/en
Application filed by Delphi Genetics Sa filed Critical Delphi Genetics Sa
Publication of AR087330A1 publication Critical patent/AR087330A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00088—Details for redistribution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente se refiere a un fago genéticamente modificado y al uso del mismo en un método para producir una biomolécula de interés.Reivindicación 1: Un fago genéticamente modificado en donde se inserta un sistema de expresión, los genes S, R y/o Q están inactivados, y los genes Int y/o Xis están inactivados.
ARP120102472A 2011-07-07 2012-07-06 Fago modificado geneticamente y uso del mismo AR087330A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11173033A EP2543720A1 (en) 2011-07-07 2011-07-07 Genetically modified phage and use thereof
US13/178,402 US9920323B2 (en) 2011-07-07 2011-07-07 Genetically modified phage and use thereof

Publications (1)

Publication Number Publication Date
AR087330A1 true AR087330A1 (es) 2014-03-19

Family

ID=46458540

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120102472A AR087330A1 (es) 2011-07-07 2012-07-06 Fago modificado geneticamente y uso del mismo

Country Status (10)

Country Link
EP (1) EP2729563B1 (es)
JP (2) JP6174019B2 (es)
CN (1) CN103797113B (es)
AR (1) AR087330A1 (es)
BR (1) BR112014000248B1 (es)
CA (1) CA2841805C (es)
CL (1) CL2014000033A1 (es)
ES (1) ES2699652T3 (es)
IN (1) IN2014MN00024A (es)
WO (1) WO2013004817A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016012607A1 (en) * 2014-07-25 2016-01-28 Delphi Genetics Improved host cell for producing proteins
JP6779513B2 (ja) * 2016-07-11 2020-11-04 大学共同利用機関法人情報・システム研究機構 インビボクローニング可能な細胞株をスクリーニングするための方法、インビボクローニング可能な細胞株の製造方法、細胞株、インビボクローニング方法、及びインビボクローニングを行うためのキット

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952496A (en) * 1984-03-30 1990-08-28 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
US7153652B2 (en) * 1995-10-02 2006-12-26 The Board Of Trustees Of The Leland Stanford Junior University Mismatch repair detection
US6355412B1 (en) 1999-07-09 2002-03-12 The European Molecular Biology Laboratory Methods and compositions for directed cloning and subcloning using homologous recombination
KR100761486B1 (ko) * 2000-08-15 2007-10-04 카디오배스큘러 바이오 떼러퓨틱스, 인크. 파아지를 이용한 생리 활성 단백질 및 펩티드의 대량생산법
CA2435956C (en) 2001-02-23 2012-07-10 Universite Libre De Bruxelles Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to toxic molecule
JP2006502691A (ja) 2001-12-12 2006-01-26 イーライ・リリー・アンド・カンパニー 発現系
EP1859043A4 (en) * 2005-02-22 2009-06-03 David Tabaczynski PHAGEN DERIVED VECTORS AND PROCEDURE FOR PROTEIN EXPRESSION
GB0709061D0 (en) 2007-05-11 2007-06-20 Avecia Biolog Ltd Expression system

Also Published As

Publication number Publication date
BR112014000248A2 (pt) 2017-07-11
ES2699652T3 (es) 2019-02-12
BR112014000248B1 (pt) 2021-01-19
WO2013004817A1 (en) 2013-01-10
CA2841805C (en) 2020-12-15
CA2841805A1 (en) 2013-01-10
JP6174019B2 (ja) 2017-08-02
CL2014000033A1 (es) 2014-12-12
IN2014MN00024A (es) 2015-06-12
JP2014520519A (ja) 2014-08-25
EP2729563B1 (en) 2018-09-12
CN103797113A (zh) 2014-05-14
JP2017158551A (ja) 2017-09-14
CN103797113B (zh) 2018-08-10
EP2729563A1 (en) 2014-05-14

Similar Documents

Publication Publication Date Title
CY1123142T1 (el) Βελτιωμενες μεθοδοι για την παραγωγη θετων κυτταρικων θεραπειων
CL2017003356A1 (es) Moduladores cot y métodos de uso de los mismos
CY1123515T1 (el) Μεθοδοι αγωγης μιας ταυπαθειας
CY1124024T1 (el) Νεες ctla4-ig ανοσοπροσκολλητινες
CL2017001736A1 (es) Anticuerpos anti-cd47 y uso de los mismos.
CL2016002455A1 (es) Anticuerpos multiespecíficos.
AR103161A1 (es) Anticuerpos antimiostatina y regiones fc variantes así como métodos de uso
NZ733055A (en) Anti-c10orf54 antibodies and uses thereof
PE20151613A1 (es) Construcciones de anticuerpos para cdh19 y cd3
PE20210107A1 (es) Anticuerpos anti-cd3 y metodos de uso
CL2015001911A1 (es) Sistema de verificación para construcciones seguras y para verificar construcciones seguras.
CL2017000506A1 (es) Nuevos anticuerpos anti-mfi2 y metodos de uso
NI201600138A (es) Nanopartículas terapéuticas que comprenden un agente terapéutico, y metodos para su elaboración y uso
BR112016018891A2 (pt) anticorpos anti-dll3 e conjugados de fármacos para uso em melanoma
ECSP14005975A (es) Anticuerpos anti-PHF-tau y sus usos
AR090903A1 (es) Anticuerpos e inmunoconjugados anti-pmel17
UY34782A (es) Anticuerpos humanos para fel d1 y métodos para usarlos.
AR093446A1 (es) Anticuerpos de antihemaglutinina y metodos de uso
ECSP12012105A (es) Antídotos de Anticoagulantes
BR112015030356A2 (pt) métodos de tratamento de uma taupatia
UY35718A (es) Anticuerpos anti-csf-1r: métodos de expresión de los mismos.
CR20150211A (es) Compuestos diméricos
MY181693A (en) Dual quencher probes
UY36617A (es) Proteínas de fusión inmunogénicas para el tratamiento del cáncer
AR090668A1 (es) Anticuerpo anti-adamts-5, derivados y usos del mismo

Legal Events

Date Code Title Description
FG Grant, registration